Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

National Healthcare (NHC) Net Income towards Common Stockholders (2016 - 2025)

Historic Net Income towards Common Stockholders for National Healthcare (NHC) over the last 17 years, with Q3 2025 value amounting to $41.0 million.

  • National Healthcare's Net Income towards Common Stockholders fell 396.02% to $41.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $103.4 million, marking a year-over-year decrease of 1659.46%. This contributed to the annual value of $102.1 million for FY2024, which is 5636.26% up from last year.
  • National Healthcare's Net Income towards Common Stockholders amounted to $41.0 million in Q3 2025, which was down 396.02% from $24.1 million recorded in Q2 2025.
  • Over the past 5 years, National Healthcare's Net Income towards Common Stockholders peaked at $105.3 million during Q2 2021, and registered a low of -$3.5 million during Q3 2021.
  • Its 5-year average for Net Income towards Common Stockholders is $22.0 million, with a median of $15.9 million in 2023.
  • Per our database at Business Quant, National Healthcare's Net Income towards Common Stockholders tumbled by 12755.67% in 2021 and then skyrocketed by 63655.71% in 2023.
  • National Healthcare's Net Income towards Common Stockholders (Quarter) stood at $10.7 million in 2021, then tumbled by 47.96% to $5.6 million in 2022, then surged by 401.7% to $28.0 million in 2023, then tumbled by 78.44% to $6.0 million in 2024, then soared by 580.2% to $41.0 million in 2025.
  • Its last three reported values are $41.0 million in Q3 2025, $24.1 million for Q2 2025, and $32.3 million during Q1 2025.